Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%

Healthcare

Page 77
  1. Jan 08, 2026 · 09:23 · ZYUS

    ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

    ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

    01
  2. Jan 08, 2026 · 08:56 · LOBE

    Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

    Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

    02
  3. Jan 08, 2026 · 08:01 · BIOV

    BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

    BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

    03
  4. Jan 08, 2026 · 08:00 · AIDR

    Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care

    Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care

    04
  5. Jan 08, 2026 · 07:34 · EPRX

    Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy

    Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy

    05
  6. Jan 08, 2026 · 06:30 · NGEN

    NervGen Pharma Begins Trading on Nasdaq Today

    NervGen Pharma Begins Trading on Nasdaq Today

    06
  7. Jan 08, 2026 · 04:48 · CNVI

    Conavi files amended final prospectus

    Conavi files amended final prospectus

    07
  8. Jan 08, 2026 · 04:40 · DRUG

    Bright Minds prices shares of offering at $90 each

    Bright Minds prices shares of offering at $90 each

    08
  9. Jan 08, 2026 · 04:00 · RKV

    Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors

    Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors

    09
  10. Jan 08, 2026 · 02:48 · 4565

    Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

    Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

    10
  11. Jan 07, 2026 · 21:38 · CNVI

    Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

    Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

    11
  12. Jan 07, 2026 · 21:33 · DRUG

    Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

    Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

    12
  13. Jan 07, 2026 · 18:01 · MYTC

    MyndTec Inc. Completes Additional Tranche of Non-Brokered Private Placement

    MyndTec Inc. Completes Additional Tranche of Non-Brokered Private Placement

    13
  14. Jan 07, 2026 · 17:56 · VPT

    Ventripoint increases financing to $1-million

    Ventripoint increases financing to $1-million

    14
← Newer Older →